UNIQUE PHARM
GenericsUNIQUE PHARM is a generic drug manufacturer focused on Cardiovascular, Neurology, Infectious Disease.
UNIQUE PHARM's Key Drugs
UNIQUE PHARM's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
UNIQUE PHARM's Recent FDA Approvals
New NDA/BLA approvals for UNIQUE PHARM over the last two years — novel drugs only, excluding generics and label supplements.
UNIQUE PHARM's Therapeutic Areas
UNIQUE PHARM's approved drugs and pipeline span 5 therapeutic areas, led by Cardiovascular and Neurology, across 0 biologic and 1 small-molecule drug. Weighted by commercial stage — approved drugs count most, then late-stage trials.
UNIQUE PHARM's Top Competitors
UNIQUE PHARM's closest competitors by therapeutic-area and drug-target overlap include Pfizer, BAUSCH AND LOMB INC, and APOTHECON. Ranked by overlap in therapeutic areas and drug targets across approved drugs and pipeline.
UNIQUE PHARM Pipeline Snapshot
Active clinical trials for UNIQUE PHARM across all therapeutic areas, from ClinicalTrials.gov.
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Cardiovascular pipeline focus
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (0)
Company Info
- First Approval
- 2004-09-10
- Latest
- 2026-06-30
- Applications
- 24